QUADRA: A phase II, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) in 4th or later line of therapy: Results from the tBRCAmut subset

Journal article

Open access

Peer reviewed

K.N. Moore, A.A. Secord, M. Geller, D.S. Miller, N.G. Cloven, G.F. Fleming, A.E. Wahner Hendrickson, M. Azodi, P. DiSilvestro, A. Oza, …

Annals of oncology, Vol.29, pp.viii337-viii337

10/2018

PMID: 32136795

Files and links (1)

url

https://doi.org/10.1093/annonc/mdy285.152View

Published (Version of record) Open

4 Record Views

Title: QUADRA: A phase II, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) in 4th or later line of therapy: Results from the tBRCAmut subset
Creators: K.N. Moore - University of Oklahoma
A.A. Secord - Duke Medical Center
M. Geller - University of Minnesota Medical Center
D.S. Miller - The University of Texas Southwestern Medical Center
N.G. Cloven - Texas Oncology
G.F. Fleming - University of Chicago
A.E. Wahner Hendrickson - Medical Oncology, Mayo Clinic, Rochester, NY, USA
M. Azodi - Yale University
P. DiSilvestro - Providence College
A. Oza - University Health Network
M. Cristea - City Of Hope National Medical Center
J.S. Berek - Obstetrics & Gynecology, Stanford Women's Cancer Center, Stanford, CA, USA
J.K. Chan - Sutter Health
B.J. Rimel - Cedars-Sinai Medical Center
Y. Li - Tesaro
K. Luptakova - Tesaro
R. Clark - Tesaro
U.A. Matulonis - Harvard University
B.J. Monk - University of Arizona
Publication Details: Annals of oncology, Vol.29, pp.viii337-viii337
Publisher: Elsevier Ltd
Identifiers: 991005968884102656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article